I have got too lazy after I started using twitter. So instead of posting news story in my blog I just updated my twitter @clinicalsearch about Dr Josh Mylne from the Institute for Molecular Bioscience (IMB) at University of Queensland receiving research fund to support research on plants to produce pharmaceutical drugs http://digs.by/10R9 My first thoughts [...]
Filed under: Genetically modified, transgenomics | Tagged: health sciences global business unit, Oracle health sciences global business unit | 1 Comment »
